# Arbutus Biopharma Corp: Form 8-K, filed Apr 3, 2025

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2025-04-03
- Accepted by EDGAR: Apr 3, 2025, 16:11 ET
- Period: 2025-03-28
- Accession: 0001447028-25-000093
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000144702825000093/abus-20250328.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000144702825000093/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000144702825000093/abus-20250328.htm

Filed Apr 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001447028-25-000093. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
